Navigation Links
Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
Date:5/31/2011

g products in any market, or at any particular time, or that such products will achieve any particular revenue levels. In particular, management's expectations could be affected by, among other things, unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; unexpected regulatory actions or delays or government regulation generally; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry and general public pricing pressures; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About NovartisLocated in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... May 5, 2015 Silver Creek Pharmaceuticals, Inc. ... Research (SBIR) grant from the National Institute of Health ... San Francisco based biotechnology company that ... tissues damaged by disease. This award will be used ... heart tissue following a heart attack. Silver ...
(Date:5/5/2015)... May 5, 2015 GW Pharmaceuticals plc ... a biopharmaceutical company focused on discovering, developing and ... platform, announced today the closing of the previously ... GW of 1,600,000 American Depositary Shares (ADSs) at ... proceeds of approximately $179.2 million (before deducting underwriting ...
(Date:5/5/2015)...  IBM Watson Health (NYSE: IBM ) today announced ... Mayo Clinic to advance patient health by applying the ... As Watson,s capabilities are applied to EHRs, ... of the medical factors that could impact an individual,s health ... customers – some of the largest and most-recognized healthcare ...
Breaking Medicine Technology:Silver Creek Pharmaceuticals Awarded NIH SBIR Grant for Smart Growth Factor Technology 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 2IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 3IBM Watson Health, Epic and Mayo Clinic to Unlock New Insights from Electronic Health Records 4
... 5, 2011 Jennerex, Inc., a private clinical-stage ... of first-in-class targeted oncolytic products for cancer, and ... specialized in the development of immunotherapeutic products, today ... 2 clinical studies of JX-594 were presented in ...
... Pharmaceuticals, Inc. (NASDAQ: QCOR ) today announced preliminary ... The Company announced the preliminary metrics in advance of the ... Executive Officer of Questcor, will present on Tuesday, April 5, ... web cast of the presentation during or after the event, ...
Cached Medicine Technology:Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 2Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 3Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 4Jennerex and Transgene Announce the Presentation of Positive Clinical Data of JX-594 in Patients With Liver Tumors 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 2Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 3Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 4Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 5Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 6Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 7Questcor Pharmaceuticals Announces Preliminary Operating Metrics for First Quarter 2011 8
(Date:5/6/2015)... NC (PRWEB) May 06, 2015 LINET ... Award of Charlotte in the small business category. The ... The Mayor’s International Community Award is given on an ... area that exhibit outstanding contributions to philanthropy. Since ... the Mayor have hosted the Mayor’s International Community Awards. ...
(Date:5/6/2015)... Lewisville, TX (PRWEB) May 06, 2015 ... (NYSE:ADPT) opened its first freestanding emergency room in Chandler ... Dignity Health Arizona General Hospital, which is also part ... To celebrate the grand opening, Dignity Health Arizona General ... the Chandler Chamber of Commerce and donated $5,000 to ...
(Date:5/5/2015)... It’s not your usual Veterans Affairs outreach ... cars and motorcycles to the 3rd Annual “Crusin Lincoln” Show ... at the Lincoln VA Clinic, 600 S. 70th St. , ... out each other’s rides, but also to talk to employees ... , Staff from the VA Nebraska-Western Iowa Health Care ...
(Date:5/5/2015)... 05, 2015 With the FCPX LUT: Monochromatic ... and easily add washed color grades to footage. A LUT ... modifying an image. The LUT changes every pixel's color to ... with 90 washed CUBE LUT files. , This plugin was ... give any footage a washed look. , CUBE LUT ...
(Date:5/5/2015)... The Journal of Pain Research has ... improve the management of chronic non-cancer pain in ... program ” , As corresponding author Professor Lyne ... and family members, managers, and researcher, identified challenges ... “work in silos”, lack of awareness regarding chronic ...
Breaking Medicine News(10 mins):Health News:LINET Americas Wins The Mayor's International Community Award in Charlotte 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2
... Americans will be diagnosed at some point in their lives ... One of the most common types, especially among women, is ... will be diagnosed with breast cancer in 2009, and more ... alone. One of the professions at the frontlines in ...
... , Teva Pharmaceuticals Hosting Local Roundtable as ... , PHILADELPHIA, JULY 24 According ... between 2000 and 2007. In an effort to bring awareness ... leading generic pharmaceutical company, is hosting a roundtable forum on July ...
... drop in estrogen, experts say , FRIDAY, July 24 ... involves removal of both ovaries, nearly doubles a younger ... study has found. , "It,s possible that vulnerability to ... in estrogen levels or potentially long-term use of hormone ...
... , PITTSBURGH, July 24 ... organizations in Pennsylvania to assist programs that are supported by ... Grant Program, which reinforces the company,s appreciation for those employees ... , Highmark recognizes that its ...
... PITTSBURGH, July 24 Cardiorobotics, Inc., a medical device company ... of surgical and interventional applications has closed on an $11.6 ... was led by Eagle Ventures and its co-investors, the Pittsburgh ... investors. , , Funds raised ...
... COLUMBIA, S.C., July 24 UCI Medical Affiliates, ... the former Executive Vice-President of Finance, Chief Financial Officer, and ... on July 23, 2009 in federal court to criminal charges ... the Securities and Exchange Commission. On the eight reports ...
Cached Medicine News:Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 2Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 3Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 4Health News:Breast cancer research highlights from the American Association of Physicists in Medicine meeting in Anaheim, July 26-30 5Health News:Government Officials, Community Leaders Invited to Come Together to Examine the Rising Cost of Healthcare 2Health News:Ovary Removal May Play a Role in Lung Cancer 2Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 2Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 3Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 4Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 5Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 6Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 7Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 8Health News:Highmark Inc. Awards $14,000 to 28 Pennsylvania Nonprofit Organizations 9Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 2Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 3Health News:Cardiorobotics Closes $11.6M Series A Financing to Advance Clinical Development of Snake Robot for Surgery 4Health News:UCI Medical Affiliates, Inc.'s Internal Investigation Leads to Former Executive Officer Pleading Guilty to Criminal Charges 2
...
Designed to minimize emblolic debris in SVGs and carotids...
... EECP therapy extends the ability ... to treat coronary artery disease, and ... of participating in the treatment of ... drugs. Vasomedical's EECP therapy provides a ...
... The dual lumen petite ... 1.0 mm catheter (each lumen) ... Dual oval lumen catheters offer ... maximum catheter strength. Dual lumen ...
Medicine Products: